UroGen Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
CEOElizabeth Barrett
CEOElizabeth Barrett
Employees235
Employees235
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded2004
Founded2004
Employees235
Employees235
URGN Key Statistics
Market cap835.07M
Market cap835.07M
Price-Earnings ratio-5.44
Price-Earnings ratio-5.44
Dividend yield—
Dividend yield—
Average volume1.36M
Average volume1.36M
High today$18.90
High today$18.90
Low today$17.94
Low today$17.94
Open price$18.81
Open price$18.81
Volume1.39M
Volume1.39M
52 Week high$21.71
52 Week high$21.71
52 Week low$3.42
52 Week low$3.42
URGN News
Simply Wall St 7d
Breakeven On The Horizon For UroGen Pharma Ltd.We feel now is a pretty good time to analyse UroGen Pharma Ltd.'s ( ) business as it appears the company may be on the cusp of a considerable accomplishment. Ur...
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own URGN. This list is generated using Robinhood data, and it’s not a recommendation.